Ardelyx ARDX
NASDAQ ARDX
$3.01 +0.08 (+2.73%)
At close: Nov 10, 2026 · 4:00 PM EST

Ardelyx (ARDX) Preferred Stock Liabilities (2013)

Updated

Ardelyx (ARDX) reported Preferred Stock Liabilities of $56.16 million for Q4 2013.

Analysis

Ardelyx (ARDX) Preferred Stock Liabilities (2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Ardelyx 736.27 Mn -333.66 Mn 123.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 56.16 Mn
API Access

Ardelyx Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ARDX&period=max&api_key=YOUR_API_KEY